Replies to post #250711 on Biotech Values

[DewDiligence]

OCUL—I am impressed with their executive hires announced this morning. along w/ Dr. Kaiser, this is really a great team.

Dr. Kaiser’s role with the company has been reduced, according to an 8-K filing yesterday:

https://www.sec.gov/ix?doc=/Archives/edgar/data/1393434/000110465924041224/tm2410214d1_8k.htm

On March 28, 2024, Ocular Therapeutix, Inc. modified its employment agreement with Peter Kaiser, M.D., its Medical Director, to eliminate his 50% service requirement under the employment agreement.

Emphasis added.